Sanofi-Regeneron's Praluent cuts cholesterol in Odyssey trials

PARIS, June 11 (Reuters) - France's Sanofi and partner Regeneron Pharmaceuticals said on Sunday their anti-cholesterol drug Praluent recorded positive results in its first dedicated studies involving patients with diabetes and high cholesterol.

by reutersCOMPANYNEWS via Endless Supplies .Biz - News